Correction to: Ritlecitinib, a JAK3 /TEC inhibitor, modulates the markers of celiac autoimmunity in alopecia areata and vitiligo patients (Archives of Dermatological Research, (2025), 317, 1, (280), 10.1007/s00403-024-03784-6)

Rok Seon Choung; Jyoti Ramakrishna; Vivek Pradhan; Brett King; Emma Guttman-Yassky; Elena Peeva; Joseph A. Murray

doi:10.1007/s00403-025-04136-8

Correction to: Ritlecitinib, a JAK3 /TEC inhibitor, modulates the markers of celiac autoimmunity in alopecia areata and vitiligo patients (Archives of Dermatological Research, (2025), 317, 1, (280), 10.1007/s00403-024-03784-6)

Rok Seon Choung
, Jyoti Ramakrishna
, Vivek Pradhan
, Brett King
, Emma Guttman-Yassky
, Elena Peeva
, Joseph A. Murray

Research output: Contribution to journal › Comment/debate

Abstract

The article “Ritlecitinib, a JAK3 /TEC inhibitor, modulates the markers of celiac autoimmunity in alopecia areata and vitiligo patients”, written by Rok Seon Choung, Jyoti Ramakrishna, Vivek Pradhan, Brett King, Emma Guttman-Yassky, Elena Peeva and Joseph A. Murray, was originally published under exclusive license to Springer-Verlag GmbH Germany, part of Springer Nature.

Original language	English
Article number	546
Journal	Archives of Dermatological Research
Volume	317
Issue number	1
DOIs	https://doi.org/10.1007/s00403-025-04136-8
State	Published - Dec 2025

Access to Document

10.1007/s00403-025-04136-8

Fingerprint

Dive into the research topics of 'Correction to: Ritlecitinib, a JAK3 /TEC inhibitor, modulates the markers of celiac autoimmunity in alopecia areata and vitiligo patients (Archives of Dermatological Research, (2025), 317, 1, (280), 10.1007/s00403-024-03784-6)'. Together they form a unique fingerprint.

Cite this

Choung, R. S., Ramakrishna, J., Pradhan, V., King, B., Guttman-Yassky, E., Peeva, E., & Murray, J. A. (2025). Correction to: Ritlecitinib, a JAK3 /TEC inhibitor, modulates the markers of celiac autoimmunity in alopecia areata and vitiligo patients (Archives of Dermatological Research, (2025), 317, 1, (280), 10.1007/s00403-024-03784-6). Archives of Dermatological Research, 317(1), Article 546. https://doi.org/10.1007/s00403-025-04136-8

@article{2cbff751920345839d707626a33bdfb1,

title = "Correction to: Ritlecitinib, a JAK3 /TEC inhibitor, modulates the markers of celiac autoimmunity in alopecia areata and vitiligo patients (Archives of Dermatological Research, (2025), 317, 1, (280), 10.1007/s00403-024-03784-6)",

abstract = "The article “Ritlecitinib, a JAK3 /TEC inhibitor, modulates the markers of celiac autoimmunity in alopecia areata and vitiligo patients”, written by Rok Seon Choung, Jyoti Ramakrishna, Vivek Pradhan, Brett King, Emma Guttman-Yassky, Elena Peeva and Joseph A. Murray, was originally published under exclusive license to Springer-Verlag GmbH Germany, part of Springer Nature.",

author = "Choung, \{Rok Seon\} and Jyoti Ramakrishna and Vivek Pradhan and Brett King and Emma Guttman-Yassky and Elena Peeva and Murray, \{Joseph A.\}",

note = "Publisher Copyright: {\textcopyright} The Author(s) 2025.",

year = "2025",

month = dec,

doi = "10.1007/s00403-025-04136-8",

language = "English",

volume = "317",

journal = "Archives of Dermatological Research",

issn = "0340-3696",

publisher = "Springer Nature",

number = "1",

}

Choung, RS, Ramakrishna, J, Pradhan, V, King, B, Guttman-Yassky, E, Peeva, E & Murray, JA 2025, 'Correction to: Ritlecitinib, a JAK3 /TEC inhibitor, modulates the markers of celiac autoimmunity in alopecia areata and vitiligo patients (Archives of Dermatological Research, (2025), 317, 1, (280), 10.1007/s00403-024-03784-6)', Archives of Dermatological Research, vol. 317, no. 1, 546. https://doi.org/10.1007/s00403-025-04136-8

Correction to: Ritlecitinib, a JAK3 /TEC inhibitor, modulates the markers of celiac autoimmunity in alopecia areata and vitiligo patients (Archives of Dermatological Research, (2025), 317, 1, (280), 10.1007/s00403-024-03784-6). / Choung, Rok Seon; Ramakrishna, Jyoti; Pradhan, Vivek et al.
In: Archives of Dermatological Research, Vol. 317, No. 1, 546, 12.2025.

Research output: Contribution to journal › Comment/debate

TY - JOUR

T1 - Correction to

T2 - Ritlecitinib, a JAK3 /TEC inhibitor, modulates the markers of celiac autoimmunity in alopecia areata and vitiligo patients (Archives of Dermatological Research, (2025), 317, 1, (280), 10.1007/s00403-024-03784-6)

AU - Choung, Rok Seon

AU - Ramakrishna, Jyoti

AU - Pradhan, Vivek

AU - King, Brett

AU - Guttman-Yassky, Emma

AU - Peeva, Elena

AU - Murray, Joseph A.

PY - 2025/12

Y1 - 2025/12

N2 - The article “Ritlecitinib, a JAK3 /TEC inhibitor, modulates the markers of celiac autoimmunity in alopecia areata and vitiligo patients”, written by Rok Seon Choung, Jyoti Ramakrishna, Vivek Pradhan, Brett King, Emma Guttman-Yassky, Elena Peeva and Joseph A. Murray, was originally published under exclusive license to Springer-Verlag GmbH Germany, part of Springer Nature.

AB - The article “Ritlecitinib, a JAK3 /TEC inhibitor, modulates the markers of celiac autoimmunity in alopecia areata and vitiligo patients”, written by Rok Seon Choung, Jyoti Ramakrishna, Vivek Pradhan, Brett King, Emma Guttman-Yassky, Elena Peeva and Joseph A. Murray, was originally published under exclusive license to Springer-Verlag GmbH Germany, part of Springer Nature.

UR - https://www.scopus.com/pages/publications/105000041951

U2 - 10.1007/s00403-025-04136-8

DO - 10.1007/s00403-025-04136-8

M3 - Comment/debate

C2 - 40072622

AN - SCOPUS:105000041951

SN - 0340-3696

VL - 317

JO - Archives of Dermatological Research

JF - Archives of Dermatological Research

IS - 1

M1 - 546

ER -

Choung RS, Ramakrishna J, Pradhan V, King B, Guttman-Yassky E, Peeva E et al. Correction to: Ritlecitinib, a JAK3 /TEC inhibitor, modulates the markers of celiac autoimmunity in alopecia areata and vitiligo patients (Archives of Dermatological Research, (2025), 317, 1, (280), 10.1007/s00403-024-03784-6). Archives of Dermatological Research. 2025 Dec;317(1):546. doi: 10.1007/s00403-025-04136-8